What is SCTX's current stock price?

SCTX (Scribe Therapeutics Inc.) is currently trading at $22.00 with a market cap of $356.0M.

What sector is Scribe Therapeutics Inc. in?

Scribe Therapeutics Inc. (SCTX) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

SCTX Scribe Therapeutics Inc.

NASDAQHealthcare

$22.00+46.67%ClosedMarket Cap: $356.0M

As of 2026-07-24

Why SCTX matters now

Scribe Therapeutics Inc. (SCTX) is a US stock in Healthcare. The latest InvestLog snapshot shows $22.00 with +46.67% on the session and $356.0M in market capitalization.

The latest indexable market news headline is "Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering" from GlobeNewsWire.

Latest News

Scribe Therapeutics Announces Pricing of Upsized Initial Public OfferingGlobeNewsWire · 2026-07-23

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

NASDAQ

Beta

0.00

Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. The company engineers proprietary technologies to target the genetic drivers of disease, with an initial focus on atherosclerotic cardiovascular disease (ASCVD), aiming to shift treatment from chronic care to preventative intervention.